title: The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
authors.affiliation: Department of Health Policy and Management, Harvard School of Public Health, Boston, USA.
authors.forename: Michelle M
authors.initials: MM
authors.lastname: Mello
authors.forename: David M
authors.initials: DM
authors.lastname: Studdert
authors.forename: Troyen A
authors.initials: TA
authors.lastname: Brennan
mesh_terms: D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D008484:Medicaid / Q000331:legislation & jurisprudence*; D011306:Prescription Fees / Q000331:legislation & jurisprudence*; D011907:Rate Setting and Review / Q000331:legislation & jurisprudence*; D013221:State Health Plans / Q000331:legislation & jurisprudence*; D014481:United States